# Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

> **NCT06531629** · — · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 72408 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **PROCEDURE:** Surgery, radiation therapy and chemotherapy

## Key facts

- **NCT ID:** NCT06531629
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 72408 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531629, "Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06531629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*